Arthritis Research & Therapy, 2026 Predicting clinical response in psoriatic arthritis through integrative analysis of transcriptomics and proteomics Bentvelzen M., el Bouhaddani S., Spierings J. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationSerum | | | | |
International Journal of Cancer, 2026
ULK4
and
CDKN2A
polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance Sánchez‐Maldonado J., Macauda A., Cabrera‐Serrano A. et al. Olink Target 96OncologyHematologyPathophysiologyPlasma | | | | |
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026 Neurology and inflammatory‐associated plasma protein biomarkers linked to dementia progression, brain aging pathology Schweitzer N., Son S., Iordanova B. et al. Olink Target 96Olink Target 48NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Naunyn-Schmiedeberg's Archives of Pharmacology, 2026 Constructing a protein–protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses Tian D., Yang Z., Zhao L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesHepatologyPathophysiologyPlasma | | | | |
Skin Appendage Disorders, 2026 Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping Pan L., Li C., Yang L. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Nature, 2026 Immune evasive DNA donors and recombinases license kilobase-scale writing Tou C., Xie K., Ferreira da Silva J. et al. Olink Target 48 MouseTechnical StudiesTechnical EvaluationMouse Plasma | | | | |
Pediatric Critical Care Medicine, 2026 Distinct Blood and Lung Proteins Drive Pulmonary Capillary Leak in Children With Severe Hypoxemic Respiratory Failure Gkaifyllia A., Bruzek S., Ignjatovic V. et al. Olink Target 48Respiratory DiseasesPathophysiologyPlasmaBALF | | | | |
Nature Aging, 2026 Microglia protein profiles in CSF across Alzheimer’s disease clinical stages Blujdea E., van Bokhoven P., Martino-Adami P. et al. Olink Target 96Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationCSF | | | | |
Clinical Proteomics, 2026 Evaluation of the relationship between inflammation and typical chest pain in ST-elevation myocardial infarction Wolfermann S., Schmitz T., Raake P. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
JCO Oncology Advances, 2026 Tumor-Targeted IL-12 (PDS01ADC) With Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Nonrandomized Phase II Trial Eade A., Smith E., Monge C. et al. Olink Target 96ImmunotherapyOncologyPathophysiologyPlasma | | | | |
JCI Insight, 2026 Epithelial SLPI Expression In Severe Inflammatory Bowel Disease Relates to High IL-17 and Neutrophil Programming Nugteren S., Calado B., Simons-Oosterhuis Y. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Diabetes/Metabolism Research and Reviews, 2026 Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes Song Y., Chen X., Chang Z. et al. Olink Explore 3072/384CVDInfectious DiseasesPatient StratificationPlasma | | | | |
Diabetes, Obesity and Metabolism, 2026 Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic
CDHR2
as a Potential Therapeutic Target in
MASLD Shi Y., Huang Q., Liu Y. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma | | | | |
European Journal of Pharmacology, 2026 Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis Li Y., Xie H., Zhuang Z. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2026 Population-Scale Plasma Proteomic Profiles Associated with Chronic Periodontitis in the UK Biobank Kim S., Kim M., Kang S. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Cell, 2026 Immune-microbiome coordination defines interferon setpoints in healthy humans Babdor J., Patel R., Davidson B. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Arthritis & Rheumatology, 2026 Unveiling Endotypes in Systemic Lupus Erythematosus Through Multi‐Omic Analysis: Insights into Cardiovascular and Renal Complications Cerdó T., Woodridge L., Corrales S. et al. Olink Target 96Olink Target 96 MouseRevealImmunological & Inflammatory DiseasesCVDNephrologyPathophysiologyPatient StratificationCell Culture SupernatantSerumRat Cell Culture Supernatant | | | | |
Eye, 2026 Olink proteomics profiling platform reveals inflammatory protein biomarkers in vitreous with different degrees of proliferative vitreoretinopathy Zhao X., Han S., Jin H. et al. Olink Target 96OphthalmologyPathophysiologyPatient StratificationVitreous Humor | | | | |
Mediators of Inflammation, 2026 Integrative Multi‐Omics Identifies S100A4 as a Translational Hub Linking Environmental Bis(2‐Ethylhexyl) Phthalate (DEHP) Exposure to Glioblastoma Risk Tan S., Li Z., Du Z. et al. Olink Explore 3072/384OncologyEnvironmental Health & ToxicologyPathophysiologyPlasma | | | | |
Mediators of Inflammation, 2026 Investigating the Relationships Among Gut Microbiota, Inflammatory Cytokines, Cerebrovascular Diseases, and the Mediation Pathways Li Q., Liu X., Deng X. et al. Olink Target 96Neurovascular DiseasesPathophysiologyPlasma | | | | |